REFERENCES
1. Pedersen CT, Kay GN, Kalman
J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014;16(9):1257-1283.
2. DiFrancesco D, Camm JA.
Heart rate lowering by specific and selective I f current inhibition
with ivabradine. Drugs. 2004;64(16):1757-1765.
3. Fox K, Ford I, Steg PG,
Tendera M, Ferrari R, Investigators B. Ivabradine for patients with
stable coronary artery disease and left-ventricular systolic dysfunction
(BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. The Lancet. 2008;372(9641):807-816.
4. Fox K, Ford I, Steg PG,
Tardif J-C, Tendera M, Ferrari R. Ivabradine in stable coronary artery
disease without clinical heart failure. N Engl J Med. 2014;371(12):1091-1099.
5. Calò L, Rebecchi M, Sette
A, et al. Efficacy of ivabradine administration in patients affected by
inappropriate sinus tachycardia. Heart Rhythm. 2010;7(9):1318-1323.
6. Bohora S, Lokhandwala Y,
Parekh P, Vasavda A. Reversal of tachycardiomyopathy due to left atrial
tachycardia by ivabradine. J Cardiovasc Electrophysiol. 2011;22(3):340-342.
7. Kumar V, Kumar G, Tiwari N,
Joshi S, Sharma V, Ramamurthy R. Ivabradine as an Adjunct for Refractory
Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A
Preliminary Study. World Journal for Pediatric and Congenital
Heart Surgery. 2019;10(6):709-714.
8. Tekkeşin Aİ, Gürkan K,
Alper AT, Türkkan C, Özbilgin N. Ivabradine Terminated Incessant Right
and Left Atrial Tachycardia. J Am Coll Cardiol. 2013;62(18
Supplement 2):C47-C48.
9. Enriquez A, Malavassi F,
Saenz LC, et al. How to map and ablate left ventricular summit
arrhythmias. Heart Rhythm. 2017;14(1):141-148.
10. Yamada T, McElderry HT,
Doppalapudi H, et al. Idiopathic ventricular arrhythmias originating
from the left ventricular summit: anatomic concepts relevant to
ablation. Circulation: Arrhythmia and Electrophysiology. 2010;3(6):616-623.
11. Dukes JW, Dewland TA,
Vittinghoff E, et al. Ventricular ectopy as a predictor of heart failure
and death. J Am Coll Cardiol. 2015;66(2):101-109.
12. Lee A, Walters TE,
Gerstenfeld EP, Haqqani HM. Frequent ventricular ectopy: Implications
and Outcomes. Heart, Lung and Circulation. 2019;28(1):178-190.
13. Savelieva I, Camm AJ. I f
Inhibition with Ivabradine. Drug Saf. 2008;31(2):95-107.
14. Wahl-Schott C, Biel M.
HCN channels: structure, cellular regulation and physiological function. Cell Mol Life Sci. 2009;66(3):470.
15. Yasui K, Liu W, Opthof T,
et al. I f current and spontaneous activity in mouse embryonic
ventricular myocytes. Circ Res. 2001;88(5):536-542.
16. Stillitano F, Lonardo G,
Zicha S, et al. Molecular basis of funny current (If) in normal and
failing human heart. J Mol Cell Cardiol. 2008;45(2):289-299.
17. Chen S-A, Hsieh M-H, Tai
C-T, et al. Initiation of atrial fibrillation by ectopic beats
originating from the pulmonary veins: electrophysiological
characteristics, pharmacological responses, and effects of
radiofrequency ablation. Circulation. 1999;100(18):1879-1886.
18. Turley SL, Francis KE,
Lowe DK, Cahoon Jr WD. Emerging role of ivabradine for rate control in
atrial fibrillation. Ther Adv Cardiovasc Dis. 2016;10(6):348-352.
19. Banavalikar B, Shenthar
J, Padmanabhan D, et al. Clinical and Electrophysiological Correlates of
Incessant Ivabradine-Sensitive Atrial Tachycardia. Circulation:
Arrhythmia and Electrophysiology. 2019;12(8):e007387.
20. Kohli U, Aziz Z, Beaser
AD, Nayak HM. Ventricular arrhythmia suppression with ivabradine in a
patient with catecholaminergic polymorphic ventricular tachycardia
refractory to nadolol, flecainide, and sympathectomy. Pacing Clin
Electrophysiol. 2020.
21. Mughal LH, Houghton AR,
Khoo J. Significant suppression of premature ventricular ectopics with
ivabradine in dilated cardiomyopathy.
22. Melgari D, Brack KE,
Zhang C, et al. hERG potassium channel blockade by the HCN channel
inhibitor bradycardic agent ivabradine. Journal of the American
Heart Association. 2015;4(4):e001813.
23. Mackiewicz U, Gerges JY,
Chu S, et al. Ivabradine protects against ventricular arrhythmias in
acute myocardial infarction in the rat. J Cell Physiol. 2014;229(6):813-823.